“Pharmacokinetic (PK) and Pharmacodynamic (PD) Characteristics of BioChaperone Combo (BC Combo), the First Fixed Combination of Glargine and Lispro, in Type 1 Diabetes”, (Poster 83-LB), presented by Dr. Ulrike Hövelmann, 74th Scientific Sessions American Diabetes Association 13-17 June 2014, San Francisco, CA, (USA)

Adocia Logo

Advancing Mealtime Insulin Therapy:
Phase 3 Results for BC Lispro in Type 2 Diabetes

Tuesday, June 16, 2026 | 10:00 AM ET / 4:00 PM CET

Click Here to Register & Attend